| Home | ||||||||||||||||||||||
| Congestive Heart Failure | ||||||||||||||||||||||
| AHA ACC CHF Guidelines 2001 | ||||||||||||||||||||||
| Acute Management ESC Guideline 2005 | ||||||||||||||||||||||
| This is the first guideline for the acute management of CHF, by the European Society of Cardiology. ACC/AHA are likely not far behind. | ||||||||||||||||||||||
| BNP Review 2004 | ||||||||||||||||||||||
| Nesiritide Protocol 1 and 2 | ||||||||||||||||||||||
| CHF and Worsening Renal Function | ||||||||||||||||||||||
| CHF Mortality Predictor 2004: For LV systolic dysfunction | ||||||||||||||||||||||
| CHF In-Hospital Mortality Predictor 2005: Recursive Partitioning idetified if patient has a BUN > 43, SBP < 115, and Crt > 2.75, then in-hospital mortality was 20% | ||||||||||||||||||||||
| Diastolic Heart Failure Review 2004 | ||||||||||||||||||||||
| CHF RALES 1999 | ||||||||||||||||||||||
| CHF AHeft 2004 | ||||||||||||||||||||||
| CHF Review 2003: Reviews Neurohumoral CHF, which needs to be affected to decrease mortality | ||||||||||||||||||||||